Articles Referencing SHPG
Shire Beats Earnings in 1Q - Analyst Blog
5/3/2013, 1:32 pm from Zacks.com in Investing, Business, Earnings, Stocks
Shire's ( SHPG ) first quarter
2013 earnings (excluding special items) of 1.63 as per American
Depositary Share (ADS) beats the Zacks Consensus Estimate of $1.61.
The reported quarter's... Read >>
Earnings Plummet, Outlook Maintained at Sanofi - Analyst Blog
5/3/2013, 1:30 pm from Zacks.com in Investing, Business, Earnings, Stocks
Sanofi ( SNY ) reported first
quarter 2013 business earnings of 81 cents per American Depository
Share (ADS), below the Zacks Consensus Estimate of 89 cents.
Earnings were down 29.0% at... Read >>
Shire Settles Lawsuit with Actavis - Analyst Blog
5/1/2013, 1:48 pm from Zacks.com in Investing, Business, Stocks
Shire ( SHPG ) recently
announced that the company settled its pending litigation with
Actavis, Inc ( ACT ), formerly known
as Watson Pharmaceuticals. The litigation was primarily... Read >>
Pre-Market Most Active for Apr 22, 2013 : PWER, NOK, ZNGA, SNY, BAC, CAT, GE, STM, SHPG, SIRI, QQQ, AAPL
4/22/2013, 8:39 am from NASDAQ.com News in News Headlines, Pre-market Most Active
The NASDAQ 100
Pre-Market Indicator is up 6.63 to 2,787.09. The total
Pre-Market volume is currently 15,778,718 shares traded.
The following are the
most active stocks for the pre-market... Read >>
Positive Data on BioLineRx Treatment - Analyst Blog
4/18/2013, 7:12 pm from Zacks.com in Investing, Business, Stocks
BioLineRx Ltd. ( BLRX ) recently
announced encouraging results from a phase IIa study on BL-7040.
BioLineRx is developing BL-7040 for the treatment of inflammatory
bowel disease (IBD).... Read >>
Cytokinetics Begins CK-2127107 Study - Analyst Blog
4/5/2013, 5:08 pm from Zacks.com in Investing, Business, Stocks
Cytokinetics Inc. ( CYTK ) recently
initiated a phase I study of CK-2127107 in healthy male volunteers.
Cytokinetics is evaluating CK-2127107 for the potential improvement
of the functions... Read >>
Update on Protalix Gaucher Study - Analyst Blog
4/4/2013, 5:10 pm from Zacks.com in Investing, Business, Stocks
Protalix BioTherapeutics, Inc. ( PLX ) recently
announced the treatment of the first patient in a phase I study of
PRX-112 or oral glucocerebrosidase enzyme (GCD). Oral GCD is... Read >>
Pernix Reports Loss in 4Q - Analyst Blog
3/21/2013, 2:33 pm from Zacks.com in Investing, Business, Stocks
Pernix Therapeutics Holdings, Inc ( PTX ) posted a loss of
2 cents per share in the fourth quarter of 2012 compared to
earnings of 15 cents per share in the year-ago quarter. ... Read >>
Brazil Approves Pfizer-Protalix Gaucher Drug - Analyst Blog
3/21/2013, 10:33 am from Zacks.com in Investing, Business, Stocks
Pfizer Inc. ( PFE ) and
Protalix BioTherapeutics, Inc. ( PLX ) recently
announced the approval of their Gaucher drug, Uplyso (taliglucerase
alfa), in Brazil. Uplyso has gained approval... Read >>
Positive Results on AMAG's Feraheme - Analyst Blog
3/18/2013, 6:47 pm from Zacks.com in Investing, Business, Stocks
AMAG Pharmaceuticals Inc. ( AMAG ) recently
announced positive preliminary results from the IDA-303 study on
Feraheme (ferumoxytol). The IDA-303 study evaluated the safety and
efficacy of... Read >>
Data on Abbott's MitraClip - Analyst Blog
3/15/2013, 12:46 pm from Zacks.com in Investing, Business, Stocks
Abbott ( ABT ) recently released
positive data from the EVEREST II (Endovascular Valve Edge-to-Edge
REpair STudy) High Surgical Risk cohort. The study evaluated Abbott's MitraClip system... Read >>
Shire Buys Premacure - Analyst Blog
3/14/2013, 6:49 pm from Zacks.com in Investing, Business, Stocks
Shire plc ( SHPG ) recently
announced that the company acquired privately held Premacure
AB. Financial terms of the deal include an upfront payment along
with milestone payments to... Read >>
Corcept's Loss Narrows in 4Q - Analyst Blog
3/14/2013, 2:12 pm from Zacks.com in Investing, Business, Stocks
Corcept Therapeutics Inc. ( CORT ) posted a loss
per share of 11 cents in the fourth quarter of 2012 which was
narrower than the loss of 12 cents posted in the year-ago
quarter
Adjusted... Read >>
Simcere Gets Buyout Proposal - Analyst Blog
3/13/2013, 5:10 pm from Zacks.com in Investing, Business, Stocks
China-based Simcere Pharmaceutical Group ( SCR ) recently
announced that the company's board has received a buyout proposal
from Mr. Jinsheng Ren, New Good Management Limited, Assure... Read >>
FDA Approves Roche's New HCV Test - Analyst Blog
3/12/2013, 5:09 pm from Zacks.com in Investing, Business, Stocks
Roche ( RHHBY ) recently
announced that it has received approval from the US Food and Drug
Administration (FDA) for a next-generation viral load test.
The test uses a novel dual-probe... Read >>